Correlation Between Bank Mandiri and Cardiff Oncology

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Bank Mandiri and Cardiff Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bank Mandiri and Cardiff Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bank Mandiri Persero and Cardiff Oncology, you can compare the effects of market volatilities on Bank Mandiri and Cardiff Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bank Mandiri with a short position of Cardiff Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bank Mandiri and Cardiff Oncology.

Diversification Opportunities for Bank Mandiri and Cardiff Oncology

-0.36
  Correlation Coefficient

Very good diversification

The 3 months correlation between Bank and Cardiff is -0.36. Overlapping area represents the amount of risk that can be diversified away by holding Bank Mandiri Persero and Cardiff Oncology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cardiff Oncology and Bank Mandiri is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bank Mandiri Persero are associated (or correlated) with Cardiff Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cardiff Oncology has no effect on the direction of Bank Mandiri i.e., Bank Mandiri and Cardiff Oncology go up and down completely randomly.

Pair Corralation between Bank Mandiri and Cardiff Oncology

Assuming the 90 days horizon Bank Mandiri Persero is expected to generate 0.66 times more return on investment than Cardiff Oncology. However, Bank Mandiri Persero is 1.51 times less risky than Cardiff Oncology. It trades about 0.02 of its potential returns per unit of risk. Cardiff Oncology is currently generating about -0.15 per unit of risk. If you would invest  36.00  in Bank Mandiri Persero on October 23, 2024 and sell it today you would earn a total of  0.00  from holding Bank Mandiri Persero or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Bank Mandiri Persero  vs.  Cardiff Oncology

 Performance 
       Timeline  
Bank Mandiri Persero 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Bank Mandiri Persero has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fragile performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.
Cardiff Oncology 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Cardiff Oncology are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite nearly inconsistent fundamental indicators, Cardiff Oncology reported solid returns over the last few months and may actually be approaching a breakup point.

Bank Mandiri and Cardiff Oncology Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Bank Mandiri and Cardiff Oncology

The main advantage of trading using opposite Bank Mandiri and Cardiff Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bank Mandiri position performs unexpectedly, Cardiff Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cardiff Oncology will offset losses from the drop in Cardiff Oncology's long position.
The idea behind Bank Mandiri Persero and Cardiff Oncology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.

Other Complementary Tools

Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Transaction History
View history of all your transactions and understand their impact on performance
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes